This Article contains a typographical error in the grant number in the Acknowledgements section.
“We would like to acknowledge our funding source: the Key Program of National Natural Science Foundation of China (No. 81370126)”
should read:
“We would like to acknowledge our funding source: the Key Program of National Natural Science Foundation of China (No. 81130001)”
Additional information
The online version of the original article can be found at 10.1038/srep08191
Rights and permissions
About this article
Cite this article
Lai, T., Wang, S., Xu, Z. et al. Correction: Corrigendum: Long-term efficacy and safety of omalizumab in patients with persistent uncontrolled allergic asthma: a systematic review and meta-analysis. Sci Rep 5, 9548 (2015). https://doi.org/10.1038/srep09548
Published:
DOI: https://doi.org/10.1038/srep09548
This article is cited by
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
